Number of Shares
74,295.00
Current Holdings Value*
$9.71 Mil
% of Portfolio
1.02%
Total Estimate Gain
$838,639.64
% of Total Estimate Gain
4.37%

Franklin U.S. Core Equity (IU) Fund's Abbott Laboratories Holding Summary

As of 2025-04-30, FRANKLIN FUND ALLOCATOR SERIES held 74,295.00 shares of Abbott Laboratories(ABT), totaling $9.71 Mil. This investment constitutes 1.02% of their stock portfolio, and FRANKLIN FUND ALLOCATOR SERIES now holds 0% of the outstanding Abbott Laboratories(ABT) stock.

The initial trade took place in 2021Q2. And since then Franklin U.S. Core Equity (IU) Fund has made 3 purchases of ABT, at an average price of $117.00, for a total of 163,890.00 shares. In addition, there have been 4 sales at an average price of $113.90 for 89,595.00 shares. Based on historical transaction data and ABT's current price of $132.02, Franklin U.S. Core Equity (IU) Fund's estimated gain on his ABT holdings is $838,639.64, reflecting a 4.37% gain to date.

Franklin U.S. Core Equity (IU) Fund ABT ($132.02) Holding Chart

Franklin U.S. Core Equity (IU) Fund ABT ($132.02) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1